Exercise Prior to Allogeneic Hematologic Stem Cell Transplantation
NCT ID: NCT02273024
Last Updated: 2019-11-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
30 participants
INTERVENTIONAL
2014-10-31
2019-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This study is designed to investigate if exercise therapy administered prior to allogeneic hematologic stem cell transplantation (HSCT) can influence physical and psychological side-effects associated with HSCT. Approximately 6-weeks prior to HSCT, individuals will be randomized into either an exercise group or usual care group and followed until one year after HSCT.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Multiphasic Prehab Allo-HSCT
NCT05649371
Ambulatory Physical Exercise Program in Hematopoietic Stem Cell Transplantation Recipients
NCT00402753
Exercise During the Allogeneic Stem Cell Transplantation
NCT00883714
Effects of Exercise on Allogeneic Stem Cell Transplant
NCT02900768
Exercise and Stress Management Post Autologous and Allogeneic Transplant (BMT CTN 0902)
NCT01278927
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Exercise
Individuals will participate in weekly supervised and unsupervised exercise sessions prior to HSCT, during hospitalization and till 100 days from HSCT. Exercise will consist of endurance and resistance exercise 3-5 days a week.
Exercise
Usual Care
Usual care will have continue with standard of care treatment without any specific exercise instruction or guidance other than what is provided by the patient education team at the cancer centre.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Exercise
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* must be ambulatory without need for human assistance at time of recruitment
* medically cleared to exercise by the transplant physician
* demonstrates willingness to attend supervised sessions
* sufficient in English to ensure safety of understanding prescribed exercise guidelines, or has access to an adequate non-familial interpreter
Exclusion Criteria
* less than 4 weeks till the scheduled HSCT
* refusal to be randomized
* does not have the approval of their transplant physician
* severe or unstable neurological, cardiorespiratory, musculoskeletal disease or mental illness
17 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Princess Margaret Hospital, Canada
OTHER
Toronto Rehabilitation Institute
OTHER
University Health Network, Toronto
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jeff Lipton, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Princess Margaret Hospital, University Health Network
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Princess Margaret Hospital & Toronto Rehabilitation Institute
Toronto, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
14-7699
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.